"POS0976 Apremilast treatment in early oligoarticular psoriatic arthrit" by L Gossec, LC Coates et al.
 

POS0976 Apremilast treatment in early oligoarticular psoriatic arthritis (PsA) improves clinical and patient-reported outcomes for up to 48 weeks - data from the Foremost study

Document Type

Abstract

Link to Full Text

 

Plum Print visual indicator of research metrics
PlumX Metrics
  • Usage
    • Abstract Views: 5
  • Captures
    • Readers: 2
see details

Share

COinS